What is the role of anemia in risk of dementia in veterans with chronic kidney disease?
New Research Suggested That Veterans Exposed to Agent Orange Have Increased Risk of Developing Progressive Blood Cancers, Such as MPNs
For the first time, new research findings have suggested that veterans exposed to Agent Orange might be at increased risk of developing progressive blood cancers, such as myeloproliferative neoplasms (MPNs).
In planning and preparing for the future possibility of large-scale combat operations, military medicine might have to decide which wounded warriors can have delayed evacuations. One issue is the need for blood products.
Immune abnormalities persist in young adult classical Hodgkin lymphoma (YAcHL) patients long after cure. Yet, new research presented at the most recent Annual ASH Meeting and Exposition in New Orleans pointed out the difficulties in assessing whether those issues existed prior to diagnosis.
An estimated 1 in 10 Americans and 1 in 4 veterans has diabetes, not only putting them at increased risk for problems such as heart and kidney disease, but also making them more prone to complications such as infection and bleeding following surgery.
Most hospitalizations in military servicemembers for exertional rhabdomyolysis, a syndrome of muscle breakdown following exercise, are associated with heat illness and present with lower creatine kinase levels than cases without associated heat illness, according to a recent study.
Sickle cell trait (SCT), a condition in which a person has one abnormal allele of the hemoglobin beta gene, affects an estimated 5.02% of non-Hispanic blacks, 1.08% of Hispanics and 0.1% of whites in the U.S. military.
In less than two decades, the advent of targeted therapies transformed chronic myeloid leukemia (CML) from a death sentence with a five-year survival rate of just 22% to a chronic condition with five-year survival exceeding 90%.
Patients with acute myeloid leukemia (AML) face difficult choices if their cancer recurs. Without treatment, survival is a matter of months.
Even though the rate of complete remission of acute promyelocytic leukemia (APL) is currently more than 90% because of the use of all-trans retinoic acid (ATRA) with arsenic trioxide (ATO), hemorrhagic mortality has emerged as the most significant barrier to APL-induced remission, according to a new study.
COVID-19 cases range dramatically from severity, from asymptomatic to self-limited influenza-like illness to severe respiratory failure or even death.
Does universal access to healthcare make any difference in health screening for pediatric acute lymphoblastic leukemia (ALL) survivors?
The landmark Systolic Blood Pressure Intervention Trial (SPRINT) quickly changed the standard treatment of patients at high cardiovascular risk in the U.S.
For much of the history of modern medicine, whole blood was the best—and only—option for patients needing transfusion after surgery or major trauma.
Invasive fungal disease (IFD) is a highly morbid complication in patients with hematologic conditions including acute myeloid leukemia (AML), whose risk is increased due to both the disease itself and the treatments for it.
While arterial stiffening is increasingly considered an important risk factor for Alzheimers disease (AD) and related dementias, the mechanisms behind that have been poorly understood.
While recent studies have identified a significant and increasing disparity in survival among African American and Caucasian patients diagnosed with multiple myeloma in the United States, that does not appear to be the case at the VA.
Some types of altered red blood cells can affect patients’ ability to safely exert themselves. It has been unknown, however, whether that was the case with altered red blood cell (RBC) deformability reported in veterans with Gulf War Illness (GWI).
Without treatment, even patients diagnosed with early stage hepatocellular carcinoma (HCC) have a median survival of just over a year. Patients with advanced stage disease at diagnosis will likely see just one change of season.
Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) are rare myeloid clonal disorders that commonly affect the elderly population and have poor prognosis.
Anemia occurs frequently, and clinicians often underappreciate its importance, even though up to 10% of adults with incident iron deficiency anemia (IDA) could have gastrointestinal cancer, according to a new study.
A new report revealed a possible link of industrial solvents or benzene to hematopoietic cancers, specifically hairy cell leukemia.
Statins appear to have immunomodulatory and anti-inflammatory effects and appear to reduce cancer risk. A new study sought to determine if that also is the case with HIV patients, who experience chronic inflammation and immune activation.
HOUSTON—The prognosis for older patients with acute myeloid leukemia (AML) has remained dismal, even after treatment with a hypomethylating agent. Standard curative treatment for AML, which is primarily a disease of older adults with a median age of 68 years at...
AURORA, CO – Patients with melanoma who are refractory to or ineligible for immune checkpoint blockade have an urgent need for effective treatments. A report in the journal Cancers (Basel) noted that includes patients who lack BRAF-V600E/K mutations and is often the...
LONG BEACH, CA – Among hematological malignancies, T-cell lymphomas have an extremely poor prognosis. A new review suggested that might be changing with unusual paths to cure. An article in the Lancet Haematology pointed out that, over the last three decades, little...
PHILADELPHIA — A new discovery might help explain the cause of neurotoxicity in patients undergoing CD19 directed CAR T cell immunotherapy. A report in the journal Cell discussed how new research uncovered the previously unknown presence of CD19 — a B cell molecule...
SALT LAKE CITY, UT – Since the release of the National LymphoCare Study nearly 10 years ago, few studies have described real-world practice patterns and clinical outcomes in patients with follicular lymphoma, including the use of maintenance rituximab therapy in the...
SACRAMENTO, CA – What are the complement depleting effects of humanized monoclonal antibodies and the impact of complement replacement on treatment response in patients with hard-to-treat chronic lymphocytic leukemia? A small phase 2 trial published in the Journal of...
HORSHAM, PA -- Chronic lymphocytic leukemia/small lymphocytic lymphoma is the most common adult leukemia, accounting for about 37% of all leukemias in the United States. Yet, a new study suggested that limited real-word evidence is available on the outcomes of...